MBX Biosciences Inc

MBXNASDAQ · USD
57.89USD0.00 (-6.60%)
2310

MBX Biosciences Inc (MBX) Options Open Interest

MBX options open interest is 2,992 contracts. The 2-week average daily volume is 69 contracts across the chain.

Read more

Monitoring MBX open interest helps you see where real money is positioned on MBX Biosciences Inc's options and which strikes are attracting the most commitment from traders. MBX Biosciences Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor MBX options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising MBX options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect MBX Biosciences Inc to settle.

MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinical trial designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism. The company is also developing MBX 1416, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 1 clinical trial designed as a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery.

In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies designed as a long-acting and highly potent GLP-1 and glucose-dependent insulinotropic polypeptide receptor co-agonist prodrug for treating obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where MBX open interest is concentrated. Our scanner maps MBX Biosciences Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade MBX Biosciences Inc's options open interest as the signal it is, not as an afterthought.

2026-10-16
Calls
50.0012.0014.4013.2088%+0.8606415
60.005.306.605.9578%+0.608790
65.002.805.504.1585%+0.460276
70.001.402.351.8872%+0.288728
75.000.104.902.50104%+0.28078
Puts
60.001.906.003.9580%-0.392126
50.000.104.902.50123%-0.197611
30.004.904.90373%-0.107310
40.004.904.90261%-0.160010
80.0016.0020.3018.1566%-0.92316

As of September 23, 2026

Follow the money

Track MBX open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.

Start your 14-day free trial